LENZ Therapeutics, Inc announced it has entered into a stock purchase agreement with new investor, Ridgeback Capital Investments L.P. for gross proceeds $30,000,000 on July 15, 2024.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.19 USD | +2.21% |
|
+18.12% | 0.00% |
Jul. 15 | Lenz Therapeutics Signs $30 Million Stock PIPE Deal With Ridgeback Capital | MT |
Jul. 15 | LENZ Therapeutics, Inc. announced that it expects to receive $30 million in funding | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 554M | |
+20.63% | 127B | |
+23.21% | 117B | |
+26.43% | 27.67B | |
-20.17% | 20.33B | |
-16.47% | 16.79B | |
-18.07% | 15.63B | |
+11.92% | 14.84B | |
-47.70% | 14.65B | |
+58.32% | 14.43B |
- Stock Market
- Equities
- LENZ Stock
- News LENZ Therapeutics, Inc.
- LENZ Therapeutics, Inc. announced that it expects to receive $30 million in funding